Mark S. Kleven

3.5k total citations
90 papers, 3.0k citations indexed

About

Mark S. Kleven is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Mark S. Kleven has authored 90 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Cellular and Molecular Neuroscience, 34 papers in Molecular Biology and 16 papers in Psychiatry and Mental health. Recurrent topics in Mark S. Kleven's work include Neurotransmitter Receptor Influence on Behavior (75 papers), Neuroscience and Neuropharmacology Research (35 papers) and Receptor Mechanisms and Signaling (29 papers). Mark S. Kleven is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (75 papers), Neuroscience and Neuropharmacology Research (35 papers) and Receptor Mechanisms and Signaling (29 papers). Mark S. Kleven collaborates with scholars based in France, United States and Germany. Mark S. Kleven's co-authors include Wouter Koek, Adrian Newman‐Tancredi, Lewis S. Seiden, W. L. Woolverton, William L. Woolverton, Ronan Depoortère, Laurent Bardin, L. A. Bruins Slot, E. Prinssen and Françis C. Colpaert and has published in prestigious journals such as The Journal of Immunology, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

Mark S. Kleven

89 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark S. Kleven France 34 2.4k 1.3k 472 394 313 90 3.0k
Sari Izenwasser United States 36 3.0k 1.2× 2.0k 1.5× 240 0.5× 409 1.0× 311 1.0× 131 3.8k
Mary C. Ritz United States 23 3.8k 1.6× 2.2k 1.7× 348 0.7× 386 1.0× 438 1.4× 40 4.5k
Umberto Spampinato France 41 3.4k 1.4× 2.0k 1.5× 407 0.9× 370 0.9× 501 1.6× 87 4.3k
Jeffrey Sprouse United States 25 2.1k 0.8× 1.2k 0.9× 288 0.6× 330 0.8× 481 1.5× 53 3.2k
Patrick M. Beardsley United States 30 2.1k 0.9× 1.2k 0.9× 170 0.4× 546 1.4× 289 0.9× 111 3.1k
Jack Bergman United States 35 2.9k 1.2× 1.7k 1.2× 320 0.7× 770 2.0× 578 1.8× 163 3.7k
Thomas P. Blackburn United States 30 2.2k 0.9× 1.6k 1.2× 278 0.6× 347 0.9× 440 1.4× 70 3.6k
M J Kuhar United States 35 3.5k 1.4× 2.2k 1.6× 220 0.5× 347 0.9× 609 1.9× 56 4.8k
Andrew C. McCreary Netherlands 30 1.8k 0.7× 1.0k 0.8× 146 0.3× 570 1.4× 237 0.8× 89 2.5k
Mauricette Brocco France 34 2.3k 1.0× 1.4k 1.1× 363 0.8× 374 0.9× 366 1.2× 78 3.2k

Countries citing papers authored by Mark S. Kleven

Since Specialization
Citations

This map shows the geographic impact of Mark S. Kleven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Kleven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Kleven more than expected).

Fields of papers citing papers by Mark S. Kleven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark S. Kleven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Kleven. The network helps show where Mark S. Kleven may publish in the future.

Co-authorship network of co-authors of Mark S. Kleven

This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Kleven. A scholar is included among the top collaborators of Mark S. Kleven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Kleven. Mark S. Kleven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dutta, Kaushik, Ingrid L. Scully, Mark S. Kleven, et al.. (2023). Identification of a Novel Keto Sugar Component in Streptococcus pneumoniae Serotype 12F Capsular Polysaccharide and Impact on Vaccine Immunogenicity. The Journal of Immunology. 210(6). 764–773. 1 indexed citations
2.
Newman‐Tancredi, Adrian, Ronan Depoortère, Mark S. Kleven, Marcin Kołaczkowski, & Luc Zimmer. (2021). Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders. Pharmacology & Therapeutics. 229. 107937–107937. 54 indexed citations
3.
Bardin, Laurent, Agnès L. Auclair, Mark S. Kleven, et al.. (2007). Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics. Behavioural Pharmacology. 18(2). 103–118. 38 indexed citations
4.
5.
Kleven, Mark S., et al.. (2005). Novel antipsychotic agents with 5-HT agonist properties: Role of 5-HT receptor activation in attenuation of catalepsy induction in rats. Neuropharmacology. 49(2). 135–143. 75 indexed citations
6.
Prinssen, Eric, Wouter Koek, & Mark S. Kleven. (2000). The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds. European Journal of Pharmacology. 388(1). 57–67. 20 indexed citations
7.
Prinssen, E., Wouter Koek, Françis C. Colpaert, & Mark S. Kleven. (2000). Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Behavioural Pharmacology. 11(3 & 4). 299–305. 19 indexed citations
8.
Kleven, Mark S. & Wouter Koek. (1999). Effects of benzodiazepine agonists on punished responding in pigeons and their relationship with clinical doses in humans. Psychopharmacology. 141(2). 206–212. 17 indexed citations
9.
Prinssen, E., Wouter Koek, Jacques Vignon, Jean‐Marc Kamenka, & Mark S. Kleven. (1999). Does crossing over repeated treatment with the dopamine reuptake inhibitors cocaine and BTCP modify their effects on cocaine-induced locomotion?. Psychopharmacology. 143(1). 8–14. 3 indexed citations
10.
Kleven, Mark S., F. C. Colpaert, & Wouter Koek. (1998). THE a-SELECTIVE LIGAND NE-100 ATTENUATES THE EFFECTS OF HIGH DOSES OF DIZOCILPINE IN RATS TRAINED TO DISCRIMINATE DIZOCILPINE FROM SALINE. Behavioural Pharmacology. 9(1). S49–S49. 1 indexed citations
11.
Rowlett, James K., W. L. Woolverton, Bill W. Massey, & Mark S. Kleven. (1996). Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology. 125(4). 361–370. 51 indexed citations
12.
13.
Kleven, Mark S. & Lewis S. Seiden. (1991). Repeated injection of cocaine potentiates methamphetamine-induced toxicity to dopamine-containing neurons in rat striatum. Brain Research. 557(1-2). 340–343. 6 indexed citations
14.
Kleven, Mark S. & W. L. Woolverton. (1990). Effects of bromocriptine and desipramine on behavior maintained by cocaine or food presentation in rhesus monkeys. Psychopharmacology. 101(2). 208–213. 39 indexed citations
15.
Kleven, Mark S., William L. Woolverton, & Lewis S. Seiden. (1989). Evidence that both intragastric and subcutaneous administration of methylenedioxymethylamphetamine (MDMA) produce serotonin neurotoxicity in rhesus monkeys. Brain Research. 488(1-2). 121–125. 28 indexed citations
16.
Seiden, Lewis S. & Mark S. Kleven. (1988). Lack of Toxic Effects of Cocaine on Dopamine or Serotonin Neurons in the Rat Brain. PsycEXTRA Dataset. 88. 276–89. 18 indexed citations
17.
Woolverton, W. L. & Mark S. Kleven. (1988). Multiple Dopamine Receptors and the Behavioral Effects of Cocaine. PsycEXTRA Dataset. 88. 160–84. 39 indexed citations
18.
Kleven, Mark S., et al.. (1988). Evidence for cocaine dependence in monkeys following a prolonged period of exposure. Psychopharmacology. 94(2). 288–91. 39 indexed citations
19.
Kleven, Mark S., et al.. (1988). Blockade of the discriminative stimulus effects of cocaine in rhesus monkeys with the D1 dopamine antagonist SCH 23390. Psychopharmacology. 95(3). 427–9. 49 indexed citations
20.
Kleven, Mark S. & Sheldon B. Sparber. (1987). Attenuation of isobutylmethylxanthine-induced suppression of operant behavior by pretreatment of rats with clonidine. Pharmacology Biochemistry and Behavior. 28(2). 235–241. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sari Izenwasser Breakdown of academic impact, for papers by Mary C. Ritz Breakdown of academic impact, for papers by Umberto Spampinato Breakdown of academic impact, for papers by Jeffrey Sprouse Breakdown of academic impact, for papers by Patrick M. Beardsley Breakdown of academic impact, for papers by Jack Bergman Breakdown of academic impact, for papers by Thomas P. Blackburn Breakdown of academic impact, for papers by M J Kuhar Breakdown of academic impact, for papers by Andrew C. McCreary Breakdown of academic impact, for papers by Mauricette Brocco
Rankless by CCL
2026